The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Abstract
BACKGROUND: Little is known regarding the cognitive impairment in subjects with early, drug-naïve Parkinson disease (PD). The aim of this study was to explore the proportion with mild cognitive impairment (MCI) and subtypes in an incidence cohort of untreated PD in Southern and Western Norway. METHODS: A total of 196 non-demented, drug-naive patients who were recruited after an extensive search of all new cases of PD in the area and 201 healthy control subjects completed a battery of neuropsychological tests of verbal memory, visuospatial, and attentional-executive functioning. Subjects were classified as MCI if the age- and education-corrected z-score was falling 1.5 standard deviations below the mean for at least one of the cognitive domains. RESULTS: The PD group was more impaired on all neuropsychological tests than controls, but the effect sizes were small. The largest effect size was found for verbal memory. A total of 18.9% of the patients with PD were classified as MCI, with a relative risk of 2.1 (1.2-3.6) in PD compared to the control group. Patients with PD with and without MCI did not differ significantly regarding demographic and motor features. Among PD-MCI patients, nearly two-thirds had a non-amnestic MCI subtype, and one third had an amnestic MCI subtype. CONCLUSIONS: The findings demonstrate a twofold increase in the proportion with cognitive impairment in subjects with early, untreated Parkinson disease (PD) compared to controls. This has implications for diagnosis and management of PD. AD = Alzheimer disease; aMCI-MD = amnestic multiple-domain MCI; aMCI-SD = amnestic single-domain MCI; CVLT-2 = California Verbal Learning Test II; IQCode = Informant Questionnaire on Cognitive decline in the elderly; MADRS = Montgomery and Aasberg Depression Rating Scale; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; naMCI-MD = non-amnestic multiple-domain MCI; naMCI-SD = non-amnestic single-domain MCI; PD = Parkinson disease; RR = relative risks; UPDRS = Unified Parkinson's Disease Rating Scale; VOSP = Visual Object and Space Perception Battery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mild cognitive impairment has been reported to be twice as common in PD as in people not affected by the disease (Aarsland et al. 2009).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Aarsland et al. 2009
In the citing paper
“Mild cognitive impairment (MCI) is already present in about a quarter of patients with early PD.[12][13][14]”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [12]
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationDiagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Dubois, B., Burn, D. J., Goetz, C. G., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D. W., Duyckaerts, C. J., Cummings, J., Gauthier, S. G., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,099
Self-citationCognitive profile of patients with newly diagnosed Parkinson disease
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005) · Neurology · doi:10.1212/01.wnl.0000180516.69442.95 · Cited by 1,007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review
Jorm, A. F. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000390 · Cited by 823
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A. E., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., STARKSTEIN, S. E., Weintraub, D. A., Poewe, W. H., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 690
Research works printed but not linked: 2
- Delis DC Kramer JHEK Ober BA. CVLT-II. California Verbal Learning Test. Second Edition. Adult Version. San Antonio TX: The Psychological Corporation: Harcourt Assessment Inc;
- Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol 2003;2:229–237.
Cited by
Sorted by citations
Items 301–400 of 620
Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
Halbgebauer, S., Nagl, M., Klafki, H., Haußmann, U., Steinacker, P., Oeckl, P., Kassubek, J., Pinkhardt, E. H., Ludolph, A. C., Soininen, H. S., et al. (2016) · Scientific Reports · doi:10.1038/srep26145 · Cited by 32
Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study
Hiorth, Y. H., Alves, G. W., Larsen, J. P., Schulz, J., Tysnes, O., & Pedersen, K. F. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8365-z · Cited by 31
Self-citationBiomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
Prell, T., Witte, O. W., & Großkreutz, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00195 · Cited by 32
Docherty, M. J., & Burn, D. J. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0113-7 · Cited by 31
Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies
Yu, R., & Wu, R. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-7 · Cited by 31
Chen, Y., Chen, M., Lu, C., Chen, P.-C., Chen, H.-L., Yang, I.-H., Tsai, N., & Lin, W.-C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00009 · Cited by 31
Impaired synaptic function is linked to cognition in Parkinson's disease
Selnes, P., Stav, A. L., Johansen, K. K., Bjørnerud, A., Coello, C. S., Auning, E., Kalheim, L. F., Almdahl, I. S., Hessen, E., Zetterberg, H., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.446 · Cited by 31
Self-citationCai, X., Qiao, J., Knox, T. M., Iriah, S. C., Kulkarni, P. P., Madularu, D., Morrison, T., Waszczak, B. L., Hartner, J. C., & Ferris, C. F. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.033 · Cited by 31
Komadina, N. C., Terpening, Z., Huang, Y. M., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000328165 · Cited by 30
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease
Besser, L. M., Litvan, I., Monsell, S. E., Mock, C., Weıntraub, S., Zhou, X., & Kukull, W. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.007 · Cited by 33
Lunde, K. A., Chung, J., Dalen, I., Pedersen, K. F., Linder, J., Domellöf, M., Elgh, E., Macleod, A. D., Tzoulis, C., Larsen, J. P., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.04.006 · Cited by 32
Self-citationNeuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 31
Qin, Q., Wan, H., Wang, D., Li, J., Qu, Y., Zhao, J., Li, J., & Xue, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.892493 · Cited by 29
Obtaining Reliable Estimates of Ambulatory Physical Activity in People with Parkinson’s Disease
Paul, S. S., Ellis, T. D., Dibble, L. E., Earhart, G. M., Ford, M. P., Foreman, K. B., & Cavanaugh, J. T. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160791 · Cited by 29
Zhou, Z., Müller, M. L. T. M., Kanel, P., Chua, J., Kotagal, V., Kaufer, D., Albin, R. L., Frey, K. A., & Bohnen, N. I. (2019) · Neurology · doi:10.1212/wnl.0000000000008683 · Cited by 29
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease
Beyer, M. K., Alves, G. W., Hwang, K., Babakchanian, S., Brønnick, K., Chou, Y., Dalaker, T. O., Kurz, M. W., Larsen, J. O., Somme, J. H., et al. (2013) · Movement Disorders · doi:10.1002/mds.25282 · Cited by 28
Self-citationBrain Networks and Cognitive Impairment in Parkinson's Disease
Rucco, R., Lardone, A., Liparoti, M., Lopez, E. T., Micco, R. D., Tessitore, A., Granata, C., Mandolesi, L., Sorrentino, G., & Sorrentino, P. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0985 · Cited by 27
González-Usigli, H., Ortíz, G. G., Niño, C. L. C., Mireles-Ramírez, M. A., Pacheco-Moisés, F. P., Torres-Mendoza, B. M., Hernández-Cruz, J. J., Delgado-Lara, D. L. C., & Ramírez-Jirano, L. J. (2023) · Brain Sciences · doi:10.3390/brainsci13030508 · Cited by 28
Neuropsychological Subgroups in Non-Demented Parkinson’s Disease: A Latent Class Analysis
Brennan, L., Devlin, K. M., Xie, S. X., Mechanic-Hamilton, D. J., Tran, B., Hurtig, H. H., Chen‐Plotkin, A. S., Chahine, L. M., Morley, J. F., Duda, J. E., et al. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171081 · Cited by 27
Gorges, M., Müller, H., Liepelt‐Scarfone, I., Storch, A., Dodel, R. C., Hilker-Roggendorf, R., Berg, D., Kunz, M. S., Kalbe, E., Baudrexel, S., et al. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419843447 · Cited by 31
Zheng, D., Chen, C., Song, W., Yi, Z., Zhao, P., Zhong, J., Dai, Z., Shi, H., & Pan, P. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111973 · Cited by 26
Cognitive deficits in Parkinson’s disease with excessive daytime sleepiness: a systematic review
Jester, D. J., Lee, S., Molinari, V., & Volicer, L. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1660852 · Cited by 25
Hou, Y., Wei, Q., Ou, R., Zhang, L., Yuan, X., Gong, Q., & Shang, H. (2021) · BMC Neurology · doi:10.1186/s12883-021-02360-z · Cited by 25
Weiss, A., Herman, T., Giladi, N., & Hausdorff, J. M. (2015) · Parkinson s Disease · doi:10.1155/2015/547065 · Cited by 25
Metabolomics in Parkinson’s Disease and Correlation with Disease State
Ostrakhovitch, E. A., Ono, K., & Yamasaki, T. R. (2025) · Metabolites · doi:10.3390/metabo15030208 · Cited by 24
Educational level and cognitive impairment in patients with Parkinson disease
Kierzynka, A., Kaźmierski, R., & Kozubski, W. P. (2011) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60056-6 · Cited by 24
Sentence processing in Lewy body spectrum disorder: The role of working memory
Gross, R. G., McMillan, C. T., Chandrasekaran, K., Dreyfuss, M., Ash, S., Avants, B., Cook, P. A., Moore, P., Libon, D. J., Siderowf, A. D., et al. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2011.12.004 · Cited by 24
Recognition by familiarity is preserved in Parkinson's without dementia and Lewy-Body disease.
Algarabel, S., Rodríguez, L.-A., Escudero, J. V., Fuentes, M., Peset, V., Pitarque, A., Cómbita, L. M., & Mazón, J. F. (2010) · Neuropsychology · doi:10.1037/a0019221 · Cited by 24
Clinical utility of synuclein skin biopsy in the diagnosis and evaluation of synucleinopathies
Isaacson, J. R., Freeman, R. L., & Gibbons, C. H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1510796 · Cited by 23
Kim, R., Park, S. M., Yoo, D., Jun, J., & Jeon, B. (2021) · Neurology · doi:10.1212/wnl.0000000000011852 · Cited by 23
Disrupted functional connectivity in PD with probable RBD and its cognitive correlates
Oltra, J., Campabadal, A., Segura, B., Uribe, C., Martı́, M. J., Compta, Y., Valldeoriola, F., Bargalló, N., Iranzo, Á., & Junqué, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-03751-5 · Cited by 23
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Qu, Y., Li, J., Chen, Y., Li, J., Qin, Q., Wang, D., Zhao, J., Yang, Q., Mao, Z., Xiong, Y., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11371-w · Cited by 23
Li, M., Bian, X., Zhang, J., Wang, Z., & Ma, L. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135507 · Cited by 23
Frailty in Parkinson's disease and its association with early dementia: A longitudinal study
Borda, M. G., Pérez‐Zepeda, M. U., Jaramillo-Jiménez, A., Chaudhuri, К. R., Tovar, D., Wallace, L. M. K., Batzu, L., Rockwood, K. J., Tysnes, O., Aarsland, D., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.05.004 · Cited by 22
Self-citationVerbal Memory in Parkinson’s Disease: A Combined DTI and fMRI Study
Lucas‐Jiménez, O., Díez‐Cirarda, M., Ojeda, N., Peña, J., Cabrera‐Zubizarreta, A., & Ibarretxe‐Bilbao, N. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150623 · Cited by 22
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers
Bregman, N., Thaler, A., Mirelman, A., Helmich, R. C. G., Gurevich, T., Orr‐Urtreger, A., Marder, K. S., Bressman, S., Bloem, B. R., & Giladi, N. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1271-4 · Cited by 22
Morgan, R. G., Gibbs, J. T., Melief, E. J., Postupna, N. O., Sherfield, E., Wilson, A. M., Keene, C. D., Montine, T. J., Palmiter, R. D., & Darvas, M. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.013 · Cited by 23
Lin, C., Fan, J., Lin, H.-I., Chang, C.-W., & Wu, Y. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.015 · Cited by 21
Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease
Wilson, H., de Natale, E. R., & Politis, M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00010-8 · Cited by 21
Vargese, S. S., Halonen, P., Raitanen, J. A., Forma, L., Jylhä, M. K., & Aaltonen, M. S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01867-2 · Cited by 20
Hedman, E., Hartelius, L., & Saldert, C. (2022) · International Journal of Language & Communication Disorders · doi:10.1111/1460-6984.12707 · Cited by 20
Mata, I. F., Davis, M. Y., Lopez, A. N., Dorschner, M. O., Martinez, E. D., Yearout, D., Cholerton, B., Hu, S., Edwards, K. L., Bird, T. D., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32452 · Cited by 23
Kim, J., Zhang, K., Cai, W., YorkWilliams, S. L., Cruadhlaoich, M. A. I. U., Llanes, S. J., Menon, V., & Poston, K. L. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.07.024 · Cited by 20
Trošt, M., Perovnik, M., & Pirtošek, Z. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01204 · Cited by 20
The Treatment of Cognitive Impairment Associated with Parkinson's Disease
Burn, D. J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00367.x · Cited by 19
The early course of affective and cognitive symptoms in de novo patients with Parkinson’s disease
Spalletta, G., Robinson, R. G., Cravello, L., Pontieri, F. E., Pierantozzi, M., Stefani, A., Long, J. D., Caltagirone, C., & Assogna, F. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7327-6 · Cited by 19
Impaired topographic organization in Parkinson's disease with mild cognitive impairment
Hou, Y., Wei, Q., Ou, R., Yang, J., Gong, Q., & Shang, H. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116861 · Cited by 20
Inguanzo, A., Segura, B., Sala‐Llonch, R., Monté, G. C., Abós, A., Campabadal, A., Uribe, C., Baggio, H. C., Martí, M. J., Valldeoriola, F., et al. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0939 · Cited by 19
Jumping to conclusions in untreated patients with Parkinson's disease
Costa, F. H. D. R., Averbeck, B. B., O’Sullivan, S. S., Vincent, M. B., de Rosso, A. L. Z., Lees, A. J., & Djamshidian, A. (2016) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2016.03.002 · Cited by 19
Neuropsychological impairment in prodromal Parkinson's disease
Pausch, C., Schomburg, R., Wagenpfeil, S., Wollenweber, F. A., Bayer, C., Fassbender, K. C., & Behnke, S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.10.007 · Cited by 18
Biundo, R., Fiorenzato, E., & Antonini, A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.031 · Cited by 18
Xiao, Y., Ou, R., Yang, T., Liu, K., Wei, Q., Hou, Y., Zhang, L., Lin, J., & Shang, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.749471 · Cited by 18
Pan, C., Ren, J., Hua, P., Yan, L., Yu, M., Wang, Y., Zhou, G., Zhang, R., Chen, J., & Liu, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.761817 · Cited by 18
The epidemiology of cognitive function in Parkinson's disease
Bock, M., & Tanner, C. M. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.004 · Cited by 18
Reading Comprehension in Parkinson's Disease
Murray, L. L., & Rutledge, S. (2014) · American Journal of Speech-Language Pathology · doi:10.1044/2014_ajslp-13-0087 · Cited by 18
Zhao, Y., Xu, C., Chen, Y., Gong, T., Zhuo, M., Zhao, C., Sun, Z., Chen, W., Xiang, Y., & Wang, G. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf029 · Cited by 17
Nielsen, C., Siersma, V., Ghaziani, E., Beyer, N., Magnusson, S. P., & Couppé, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207668 · Cited by 17
Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson’s Disease?
Baumeister, A. A. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000283 · Cited by 17
Pardo, J., Montal, V., Campabadal, A., Oltra, J., Uribe, C., Roura, I., Bargalló, N., Martı́, M. J., Compta, Y., Iranzo, Á., et al. (2024) · Movement Disorders · doi:10.1002/mds.29761 · Cited by 17
Beheshti, I., & Ko, J. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1375395 · Cited by 17
Vancea, R., Simonyan, K., Petracca, M., Brys, M., Rocco, A. D., Ghilardi, M., & Inglese, M. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9765-0 · Cited by 14
Understanding quantitative and qualitative figural fluency in patients with Parkinson’s disease
Goebel, S., Atanassov, L., Köhnken, G., Mehdorn, H. M., & Leplow, B. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1245-0 · Cited by 17
Facial emotion decoding in patients with Parkinson's disease
Risi, M. D., Gennaro, G. D., Picardi, A., Casciato, S., Grammaldo, L. G., D’Aniello, A., Lanni, D., Meletti, S., & Modugno, N. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1366475 · Cited by 17
The Effect of Stroke Subtypes on Baroreceptor Sensitivity, a Predict for Acute Stroke Outcome
Tsai, W., Lin, H.-C., Lai, Y., Hsu, C.-W., Huang, C., Wang, H., Su, C.-M., Su, Y., Lin, W.-C., Cheng, B., et al. (2019) · BioMed Research International · doi:10.1155/2019/7614828 · Cited by 17
Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease
Ham, J. H., Yun, H. J., Sunwoo, M.-K., Hong, J. Y., Lee, J., Sohn, Y. H., & Lee, P. H. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.01.015 · Cited by 16
Arroyave, J. A. C., Tobón, C., Revelo, J. J. S., Ochoa-Gómez, J. F., Bocanegra, Y., Gómez, L. M., & Salazar, D. A. P. (2019) · Future Neurology · doi:10.2217/fnl-2018-0048 · Cited by 18
Cortical excitability changes as a marker of cognitive impairment in Parkinson’s disease
Kamble, N., Bhattacharya, A., Hegde, S., Vidya, N., Gothwal, M., Yadav, R., & Pal, P. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113733 · Cited by 16
Neuromodulation of cognition in Parkinson's disease
Cole, R. C., Okine, D. N., Yeager, B. E., & Narayanan, N. S. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.016 · Cited by 16
An update on brain imaging in parkinsonian dementia
Petrou, M., Kotagal, V., & Bohnen, N. I. (2012) · Imaging in Medicine · doi:10.2217/iim.12.10 · Cited by 16
Progressive changes in a recognition memory network in Parkinson's disease
Segura, B., Ibarretxe‐Bilbao, N., Sala‐Llonch, R., Baggio, H. C., Martı́, M. J., Valldeoriola, F., Vendrell, P., Bargalló, N., Tolosa, E., & Junqué, C. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302822 · Cited by 16
Spencer, K. A., Paul, J., Brown, K. A., Ellerbrock, T., & Sohlberg, M. M. (2019) · American Journal of Speech-Language Pathology · doi:10.1044/2019_ajslp-19-0078 · Cited by 16
Speech Motor Sequence Learning: Acquisition and Retention in Parkinson Disease and Normal Aging
Whitfield, J. A., & Goberman, A. M. (2017) · Journal of Speech Language and Hearing Research · doi:10.1044/2016_jslhr-s-16-0104 · Cited by 16
Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES)
Sánchez‐Ferro, Á., Benito‐León, J., Louis, E. D., Mitchell, A. J., Molina‐Arjona, J. A., Trincado, R., Villarejo‐Galende, A., & Bermejo‐Pareja, F. (2012) · Movement Disorders · doi:10.1002/mds.25148 · Cited by 15
Miura, K., Matsui, M., Takashima, S., & Tanaka, K. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000381333 · Cited by 15
Joza, S., Camicioli, R. M., & Ba, F. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.287 · Cited by 15
Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults
Yılmaz, R., Behnke, S., Liepelt‐Scarfone, I., Röeben, B., Pausch, C., Runkel, A., Heinzel, S., Niebler, R., Suenkel, U., Eschweiler, G. W., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12974 · Cited by 15
Shrinkage of olfactory amygdala connotes cognitive impairment in patients with Parkinson’s disease
Ay, U., Yıldırım, Z., Erdoğdu, E., Kıçık, A., Öztürk-Işık, E., Demıralp, T., & Gurvit, H. I. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09887-y · Cited by 14
Wan, H., Wang, G., Liu, Q., & Wang, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-276 · Cited by 14
Trends and Issues in Characterizing Early Cognitive Changes in Parkinson’s Disease
Claassen, D. O., & Wylie, S. A. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0312-5 · Cited by 15
Is Amnestic Mild Cognitive Impairment a Useful Concept?
Ash, E. L., & Korczyn, A. D. (2011) · Aging Health · doi:10.2217/ahe.10.90 · Cited by 14
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
Hessen, E., Stav, A. L., Auning, E., Selnes, P., Blomsø, L., Holmeide, C. E., Johansen, K. K., Eliassen, C. F., Reinvang, I., Fladby, T., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150761 · Cited by 17
Self-citationSzeto, J. Y. Y., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988717711451 · Cited by 14
Altered N100-potential associates with working memory impairment in Parkinson’s disease
Annanmäki, T., Palmu, K., Murros, K. E., & Partanen, J. V. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1758-z · Cited by 14
Tsai, W., Lin, H., Chang, C., Chang, W., Huang, C., Cheng, K., Wang, H., Lin, W.-C., Hsiao, S.-Y., Lai, Y., et al. (2019) · International Psychogeriatrics · doi:10.1017/s1041610219001510 · Cited by 14
Cholerton, B., Poston, K. L., Yang, L., Rosenthal, L. S., Dawson, T. M., Pantelyat, A. Y., Edwards, K. L., Tian, L., Quinn, J. F., Chung, K. A., et al. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.1927995 · Cited by 14
Are dysautonomic and sensory symptoms present in early Parkinson’s disease?
Tysnes, O., Müller, B. P., & Larsen, J. O. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01380.x · Cited by 13
Self-citationVikdahl, M., Domellöf, M. E., Forsgren, L., & Håglin, L. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0573-1 · Cited by 13
Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
Buhusi, M. C., Olsen, K. A., Yang, B. Z., & Buhusi, C. V. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00114 · Cited by 13
Effects of sex and APOE on Parkinson’s Disease-related cognitive decline
Tipton, P. W., Bülbül, N. G., Crook, J. E., Quicksall, Z., Ross, O. A., Uitti, R. J., Wszołek, Z. K., & Ertekin‐Taner, N. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0071 · Cited by 13
Cognitive and Functional Trajectories in Older Adults With Prediagnostic Parkinson Disease
Bock, M., Vittinghoff, E., Bahorik, A. L., Leng, Y., Fink, H. A., & Yaffe, K. S. (2022) · Neurology · doi:10.1212/wnl.0000000000206762 · Cited by 13
Prevalence of depression in Parkinson’s disease patients in Ethiopia
Worku, D. K., Yifru, Y. M., Postels, D. G., & Gashe, F. E. (2014) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-014-0010-3 · Cited by 13
Keulen-Rouweler, B. J. V., Sturkenboom, I. H. W. M., Kottorp, A., Graff, M. J. L., der Sanden, M. W. G. N., & Steultjens, E. M. J. (2016) · Scandinavian Journal of Occupational Therapy · doi:10.1080/11038128.2016.1233291 · Cited by 13
Biomarkers of Nonmotor Symptoms in Parkinson's Disease
Konno, T., Al‐Shaikh, R. H., Deutschlander, A. B., & Uitti, R. J. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.020 · Cited by 13
Lee, J. E., Cho, K. H., Kim, M., Sohn, Y. H., & Lee, P. H. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6203-x · Cited by 13
Caviness, J. N., Adler, C. H., Hentz, J. G., Shill, H. A., Evidente, V. G. H., Driver‐Dunckley, E. D., Sabbagh, M. N., Sue, L. I., & Beach, T. G. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.03.033 · Cited by 13
Social cognitive function in neurodegenerative diseases
Chimagomedova, A. S., Lyashenko, E. A., Babkina, O. V., Яковлева, О. В., Васенина, Е. Е., & Levin, O. S. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2017117111168-173 · Cited by 13
Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s Disease
Speelberg, H. B., Daalen, J. M. J., Bloem, B. R., Gagnon, J., Post, B., & Darweesh, S. K. L. (2022) · Brain Sciences · doi:10.3390/brainsci12020199 · Cited by 14
Parkinson’s disease. Focus on early stages
Катунина, Е. А., Zalyalova, Z. A., Похабов, Д. В., Ivanova, M. Z. I., & Semenova, A. M. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-3-95-103 · Cited by 12
Neuropsychiatric Issues in Parkinson Disease
Goldman, J. G. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000353 · Cited by 12
Cognitive Performance in Parkinson’s Disease in the Brain Health Registry
Cholerton, B., Weiner, M. W., Nosheny, R. L., Poston, K. L., Mackin, R. S., Tian, L., Ashford, J. W., & Montine, T. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181009 · Cited by 12
Metadata
- Authors
- Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G.
- Affiliations
- Stavanger University Hospital (NO)
- From The Norwegian Centre for Movement Disorders (D.A., K.B., J.P.L., G.A.), Department of Neurology (J.P.L., G.A.), and Department of Psychiatry (D.A.), Stavanger University Hospital, Stavanger; Department of Neurology (O.B.T.), Haukeland University Hospital, Bergen; and School of Medicine (D.A., J.P.L., O.B.T.), University of Bergen, Norway.
- Venue
- Neurology
- Published
- 2009-03-31
- Volume
- 72
- Issue
- 13
- Pages
- 1121-1126
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2120049868
- Cited by
- 625
- References
- 25
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 24 · 2023: 19 · 2022: 33 · 2021: 34 · 2020: 33 · 2019: 39 · 2018: 34 · 2017: 44 · 2016: 43 · 2015: 40 · 2014: 40 · 2013: 53 · 2012: 48
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Parkinson's disease, mild cognitive impairment, early-stage Parkinson's disease, amnestic MCI, non-amnestic MCI, verbal memory impairment, executive function, visuospatial ability, attention, prevalence of cognitive impairment
- MeSH terms
- Aged, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Norway, Parkinson Disease, Prospective Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review